Search this site:

2003

Supplement I

LDL and Beyond: New Therapeutic Approaches to Hypercholesterolemia

Guest Editor
John C. LaRosa, M.D.

2002

Supplement I

Redefining Acute Coronary Syndrome Care (ACS) in the Era of Aggressive Revascularization

Guest Editor
Robert M. Califf, M.D.
Durham, USA

2001

Supplement I

Acute Coronary Care and Beyond: The Expanding Role of Low-Molecular-Weight Heparin

Guest Editors
J.H. Chesebro, M.D. and F.W.A. Verheugt, M.D., F.A.C.C., F.E.S.C.*
Heartcenter, University Medical Center, University of Nijmegen, Nijmegen, The Netherlands; *The Cardiovascular Institute, Mount Sinai Hospital, New York, USA

Supplement V

The INternational VErapamil SR/trandolapril STudy (INVEST) - The First Randomized Clinical Trial Evaluating Aggressive Blood Pressure Management (JNC VI) in Patients with CAD

Guest Editor
Carl J. Pepine, M.D., MACC, FESC
Division of Cardiovascular Medicine, University of Florida, College of Medicine, Gainesville, Florida, USA

2000

Supplement I

Expanding the Horizons in Unstable Coronary Artery Disease

Guest Editors
J.H. Chesebro, M.D. and F.W.A. Verheugt, M.D., F.A.C.C., F.E.S.C.*
The Cardiovascular Institute, Mount Sinai Hospital, New York, USA; *Department of Cardiology, Academic Hospital Nijmegen, Nijmegen, The Netherlands

Supplement II

Project GRACE: Guidelines for Resuscitation and Care at End-of-life

Guest Editors
L. L. Basta, M.D., FRCP, FACC, AND H. D. McIntosh, M.D., M.A.C.C.
University of South Florida, Tampa, Florida, USA

Supplement III

Best Practices for Optimally Treated Advanced Heart Failure

Guest Editor
Michael L. Bristow, M.D., Ph.D.
Division of Cardiology, University of Colorado HSC, Denver, Colo., USA

Supplement IV
Can We Prevent CHF?

Guest Editor
Gary S. Francis, M.D.

1999

Supplement I

Intrapericardial Therapeutics and Diagnostics (IPTD): Potential Advantages, Recent Advances, Experimental Direct Therapy of Cardiac Diseases and Arrhythmias

Guest Editor
David H. Spodick, M.D., D.SC., FACC
University of Massachusetts Medical School, Cardiology Division, Saint Vincent Hospital, Worcester, Massachusetts, USA

Supplement II

Triglycerides as a Risk Factor in Cardiac Heart Disease

Guest Editor
Michael Miller, M.D., F.A.C.C.
University of Maryland Medical System
Baltimore, Maryland, USA

Supplement III

The DASH Diet:
A Clinical Success Story in Hypertension Control

Guest Editor
L. J. Appel, M. D.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA

Supplement IV

Breaking the Therapeutic Barriers:
New Strategies for Acute Coronary Syndromes

Guest Editor
Christopher P. Cannon, M.D.
Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA

Supplement V

Back to the Future: A New Era for Beta Blockade in Management of Heart Failure

Guest Editors
Åke Hjalmarson, M.D., Ph.D., and Sidney Goldstein, M.D.
Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA

Supplement VI

Trials of Glycoprotein IIb-IIIa Inhibitors in Non-ST-Segment Elevation Acute Coronary Syndromes: Applicability to the Practice of Medicine in the United States

Guest Editor
W. W. Parmley, M.D.
The University of California, San Francisco, San Francisco, California, USA

1997

Supplement I, International Edition

Confronting the Challenge of Acute Coronary Syndromes

Guest Editors:
Michael E. Bertrand, M.D., F.R.C.P., F.E.S.C., F.A.C.C.
and Eugene Braunwald, A.B., M.D., M.S. (Hon), M.D. (Hon)

Supplement II

Endothelial Dysfunction, the Renin-Angiotensin System, and Nitric Oxide: Impact on Coronary Artery Disease and Therapeutic Interventions

Guest Editor
Carl J. Pepine, M.D.